In the studies of murine colon cancer and human breast cancer cell lines, the upregulation of TREX1 inhibits the activation of c-GAS, and inhibition of TREX1 expression in cancer cells can enhance anti-tumor immune response. Here, TREX1 is linked to malignant colon neoplasm.